Research ArticleNuclear Oncology
Radioimmunotherapy Targeting of HER2/neu Oncoprotein on Ovarian Tumor Using Lead-212-DOTA-AEl
Eva Horak, Frank Hartmann, Kayhan Garmestani, Chuanchu Wu, Martin Brechbiel, Otto A. Gansow, Nicholas F. Landolfi and Thomas A. Waldmann
Journal of Nuclear Medicine December 1997, 38 (12) 1944-1950;
Eva Horak
Frank Hartmann
Kayhan Garmestani
Chuanchu Wu
Martin Brechbiel
Otto A. Gansow
Nicholas F. Landolfi
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radioimmunotherapy Targeting of HER2/neu Oncoprotein on Ovarian Tumor Using Lead-212-DOTA-AEl
Eva Horak, Frank Hartmann, Kayhan Garmestani, Chuanchu Wu, Martin Brechbiel, Otto A. Gansow, Nicholas F. Landolfi, Thomas A. Waldmann
Journal of Nuclear Medicine Dec 1997, 38 (12) 1944-1950;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Tumor Cure Probability During {alpha}-RIT of Ovarian Cancer with Different Radiation Sensitivity
- Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease
- {alpha}-Radioimmunotherapy of Intraperitoneally Growing OVCAR-3 Tumors of Variable Dimensions: Outcome Related to Measured Tumor Size and Mean Absorbed Dose
- Therapeutic Efficacy and Tumor Dose Estimations in Radioimmunotherapy of Intraperitoneally Growing OVCAR-3 Cells in Nude Mice with 211At-Labeled Monoclonal Antibody MX35
- Melanoma Therapy via Peptide-Targeted {alpha}-Radiation
- Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease
- Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: Efficacy versus HER2/neu Expression
- Astatine-211-labeled Antibodies for Treatment of Disseminated Ovarian Cancer: An Overview of Results in an Ovarian Tumor Model
- Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
- Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha -emitting radionuclide, bismuth 213
- Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody
- Single-cell Cytotoxicity with Radiolabeled Antibodies